Drug Shortage Report for NOVAMOXIN

Last updated on 2020-03-26 History
Report ID 95411
Drug Identification Number 00452130
Brand name NOVAMOXIN
Common or Proper name AMOXICILLIN SUSP 250MG/5ML
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) AMOXICILLIN
Strength(s) 250MG
Dosage form(s) GRANULES FOR SUSPENSION
Route of administration ORAL
Packaging size 150ml
ATC code J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-02
Estimated end date 2020-03-31
Actual end date 2020-03-25
Shortage status Resolved
Updated date 2020-03-26
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2020-03-26 French Compare
v11 2020-03-26 English Compare
v10 2020-01-28 French Compare
v9 2020-01-28 English Compare
v8 2020-01-09 French Compare
v7 2020-01-09 English Compare
v6 2019-12-05 French Compare
v5 2019-12-05 English Compare
v4 2019-11-07 French Compare
v3 2019-11-07 English Compare
v2 2019-10-03 French Compare
v1 2019-10-03 English Compare